loadpatents
name:-0.075423002243042
name:-0.05961012840271
name:-0.015060901641846
Medina; Julio C. Patent Filings

Medina; Julio C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Medina; Julio C..The latest application filed is for "piperidinone derivatives as mdm2 inhibitors for the treatment of cancer".

Company Profile
14.55.62
  • Medina; Julio C. - San Carlos CA
  • Medina; Julio C. - Can Carlos CA
  • Medina; Julio C. - Belmont CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer
Grant 11,407,721 - Bartberger , et al. August 9, 2
2022-08-09
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
App 20220169611 - Bartberger; Michael D. ;   et al.
2022-06-02
Compounds that inhibit MCL-1 protein
Grant 11,306,107 - Brown , et al. April 19, 2
2022-04-19
Inhibitors of glucocorticoid receptor
Grant 11,208,432 - Sun , et al. December 28, 2
2021-12-28
Inhibitors Of Glucocorticoid Receptor
App 20210395295 - SUN; Daqing ;   et al.
2021-12-23
Inhibitors Of Glucocorticoid Receptor
App 20210379084 - SUN; Daqing ;   et al.
2021-12-09
Inhibitors of glucocorticoid receptor
Grant 11,124,537 - Sun , et al. September 21, 2
2021-09-21
Inhibitors of glucocorticoid receptor
Grant 11,110,103 - Sun , et al. September 7, 2
2021-09-07
Compounds That Inhibit Mcl-1 Protein
App 20210230189 - BROWN; Sean P. ;   et al.
2021-07-29
Heteroaryl-substituted triazoles as APJ receptor agonists
Grant 11,046,680 - Chen , et al. June 29, 2
2021-06-29
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
App 20210179560 - Bartberger; Michael D. ;   et al.
2021-06-17
Inhibitors Of Glucocorticoid Receptor
App 20210023095 - SUN; Daqing ;   et al.
2021-01-28
Inhibitors Of Glucocorticoid Receptor
App 20210017220 - SUN; Daqing ;   et al.
2021-01-21
Inhibitors Of Glucocorticoid Receptor
App 20210017219 - SUN; Daqing ;   et al.
2021-01-21
Inhibitors Of Glucocorticoid Receptor
App 20210002324 - SUN; Daqing ;   et al.
2021-01-07
Inhibitors of glucocorticoid receptor
Grant 10,836,789 - Sun , et al. November 17, 2
2020-11-17
Inhibitors Of Glucocorticoid Receptor
App 20200291058 - SUN; Daqing ;   et al.
2020-09-17
Triazole furan compounds as agonists of the APJ receptor
Grant 10,736,883 - Brown , et al. A
2020-08-11
Inhibitors of glucocorticoid receptor
Grant 10,723,759 - Sun , et al.
2020-07-28
Inhibitors Of Glucocorticoid Receptor
App 20200055892 - SUN; Daqing ;   et al.
2020-02-20
Inhibitors of glucocorticoid receptor
Grant 10,472,387 - Sun , et al. Nov
2019-11-12
Triazole Furan Compounds As Agonists Of The Apj Receptor
App 20190275008 - BROWN; Matthew ;   et al.
2019-09-12
Inhibitors Of Glucocorticoid Receptor
App 20190218246 - SUN; Daqing ;   et al.
2019-07-18
Triazole agonists of the APJ receptor
Grant 10,221,162 - Chen , et al.
2019-03-05
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
App 20190062276 - Bartberger; Michael D. ;   et al.
2019-02-28
Cis-morpholinone And Other Compounds As Mdm2 Inhibitors For The Treatment Of Cancer
App 20180354918 - BARTBERGER; Michael D. ;   et al.
2018-12-13
Triazole Agonists Of The Apj Receptor
App 20180319773 - CHEN; Ning ;   et al.
2018-11-08
Triazole agonists of the APJ receptor
Grant 9,868,721 - Chen , et al. January 16, 2
2018-01-16
Intermediates for preparing triazole agonists of the APJ receptor
Grant 9,845,310 - Chen , et al. December 19, 2
2017-12-19
Heteroaryl acid morpholinone compounds as MDM2 inhibitors for the treatment of cancer
Grant 9,758,495 - Gonzalez Buenrostro , et al. September 12, 2
2017-09-12
Methods for preparing triazole agonists of the APJ receptor
Grant 9,751,864 - Chen , et al. September 5, 2
2017-09-05
Triazole agonists of the APJ receptor
Grant 9,745,286 - Chen , et al. August 29, 2
2017-08-29
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
App 20170144971 - BARTBERGER; Michael D. ;   et al.
2017-05-25
Triazole agonists of the APJ receptor
Grant 9,656,997 - Chen , et al. May 23, 2
2017-05-23
Intermediates for preparing triazole agonists of the APJ receptor
Grant 9,656,998 - Chen , et al. May 23, 2
2017-05-23
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
Grant 9,593,129 - Bartberger , et al. March 14, 2
2017-03-14
Triazole agonists of the APJ receptor
Grant 9,573,936 - Chen , et al. February 21, 2
2017-02-21
Triazole Agonists Of The Apj Receptor
App 20170042871 - Chen; Ning ;   et al.
2017-02-16
Triazole Agonists Of The Apj Receptor
App 20170044131 - CHEN; Ning ;   et al.
2017-02-16
Triazole Agonists Of The Apj Receptor
App 20170042897 - Chen; Ning ;   et al.
2017-02-16
Triazole Agonists Of The Apj Receptor
App 20170042872 - CHEN; Ning ;   et al.
2017-02-16
Triazole Agonists Of The Apj Receptor
App 20170035744 - CHEN; Ning ;   et al.
2017-02-09
Triazole Agonists Of The Apj Receptor
App 20170037026 - CHEN; Ning ;   et al.
2017-02-09
Triazole Agonists Of The Apj Receptor
App 20160340336 - Chen; Ning ;   et al.
2016-11-24
Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer
Grant 9,376,425 - Bartberger , et al. June 28, 2
2016-06-28
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
App 20160137667 - BARTBERGER; Michael D. ;   et al.
2016-05-19
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
Grant 9,296,736 - Bartberger , et al. March 29, 2
2016-03-29
Heteroaryl Acid Morpholinone Compounds As Mdm2 Inhibitors For The Treatment Of Cancer
App 20160039774 - GONZALEZ BUENROSTRO; Ana ;   et al.
2016-02-11
Cis-morpholinone And Other Compounds As Mdm2 Inhibitors For The Treatment Of Cancer
App 20160002185 - BARTBERGER; Michael D. ;   et al.
2016-01-07
Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer
App 20140315895 - Bartberger; Michael D. ;   et al.
2014-10-23
Heterocyclic Compounds As Mdm2 Inhibitors For The Treatment Of Cancer
App 20140235629 - Bartberger; Michael D. ;   et al.
2014-08-21
Phenylalanine amide derivatives useful for treating insulin-related diseases and conditions
Grant 8,785,468 - Du , et al. July 22, 2
2014-07-22
Spirocyclic GPR40 modulators
Grant 8,748,462 - Brown , et al. June 10, 2
2014-06-10
Phenyl acetic acid derivatives
Grant 8,183,293 - Grillo , et al. May 22, 2
2012-05-22
Phenylanaline Amide Derivatives Useful For Treating Insulin-related Diseases And Conditions
App 20120115811 - Du; Xiaohui ;   et al.
2012-05-10
Substituted biphenyl GPR40 modulators
Grant 8,030,354 - Brown , et al. October 4, 2
2011-10-04
Heterocyclic GPR40 modulators
Grant 8,003,648 - Beck , et al. August 23, 2
2011-08-23
Spirocyclic Gpr40 Modulators
App 20110190330 - Brown; Sean P. ;   et al.
2011-08-04
Compounds and methods useful for treating asthma and allergic inflammation
Grant 7,960,567 - Brown , et al. June 14, 2
2011-06-14
Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases
Grant 7,939,538 - Fu , et al. May 10, 2
2011-05-10
Cxcr3 Antagonists
App 20110034487 - Chen; Xiaoqi ;   et al.
2011-02-10
Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
Grant 7,816,367 - Akerman , et al. October 19, 2
2010-10-19
Aryl nitrile compounds and compositions and their uses in treating inflammatory and related disorders
Grant 7,799,795 - Bergeron , et al. September 21, 2
2010-09-21
Benzo-fused Compounds For Use In Treating Metabolic Disorders
App 20100137323 - Brown; Sean P. ;   et al.
2010-06-03
Heterocyclic GPR40 modulators
Grant 7,714,008 - Beck , et al. May 11, 2
2010-05-11
Benzo-fused compounds for use in treating metabolic disorders
Grant 7,687,526 - Brown , et al. March 30, 2
2010-03-30
Heterocyclic Gpr40 Modulators
App 20100075974 - Beck; Hilary ;   et al.
2010-03-25
Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
Grant 7,649,110 - Akerman , et al. January 19, 2
2010-01-19
Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders
App 20090275598 - Akerman; Michelle ;   et al.
2009-11-05
Phenyl acetic acid derivatives as inflammation modulators
App 20090275659 - Grillo; Mark ;   et al.
2009-11-05
Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders
Grant 7,582,803 - Akerman , et al. September 1, 2
2009-09-01
Asthma and allergic inflammation modulators
Grant 7,541,383 - Fu , et al. June 2, 2
2009-06-02
Substituted biphenyl GPR40 modulators
App 20090137561 - Brown; Sean P. ;   et al.
2009-05-28
Compounds And Methods Useful For Treating Asthma And Allergic Inflammation
App 20080312270 - Brown; Matthew ;   et al.
2008-12-18
Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders
Grant 7,465,804 - Houze , et al. December 16, 2
2008-12-16
Benzo-fused compounds for use in treating metabolic disorders
App 20080119511 - Brown; Sean P. ;   et al.
2008-05-22
Tetrahydroquinazolin-4(3H)-one-related and tetrahydropyrido[2,3-D]pyrimidin-4(3H)-one-related compounds, compositions and methods for their use
Grant 7,375,102 - Fu , et al. May 20, 2
2008-05-20
Asthma and allergic inflammation modulators
App 20080085891 - Fu; Zice ;   et al.
2008-04-10
Asthma and allergic inflammation modulators
Grant 7,321,001 - Fu , et al. January 22, 2
2008-01-22
Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
App 20070244155 - Sharma; Rajiv ;   et al.
2007-10-18
Imidazolo-related compounds, compositions and methods for their use
Grant 7,271,271 - Fu , et al. September 18, 2
2007-09-18
Modulation of CCR4 function
Grant 7,262,204 - Collins , et al. August 28, 2
2007-08-28
CXCR3 antagonists
App 20070149557 - Collins; Tassie L. ;   et al.
2007-06-28
Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
App 20070142384 - Akerman; Michelle ;   et al.
2007-06-21
Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders
App 20070066647 - Akerman; Michelle ;   et al.
2007-03-22
Aryl nitrile compounds and compositions and their uses in treating inflammatory and related disorders
App 20070015773 - Bergeron; Philippe ;   et al.
2007-01-18
CCR4 antagonists
Grant 7,144,903 - Collins , et al. December 5, 2
2006-12-05
Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders
App 20060270724 - Houze; Jonathan ;   et al.
2006-11-30
Pentafluorobenzenesulfonamides and analogs
Grant 7,138,418 - Flygare , et al. November 21, 2
2006-11-21
CXCR3 antagonists
Grant 7,067,662 - Medina , et al. June 27, 2
2006-06-27
CXCR3 antagonists
App 20060116388 - Medina; Julio C. ;   et al.
2006-06-01
Substituted Quinazolin-4(3H)-one compounds, compositions, and methods for their use
Grant 7,053,215 - Medina , et al. May 30, 2
2006-05-30
Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases
App 20060069099 - Fu; Zice ;   et al.
2006-03-30
Tetrahydroquinazolin-4(3H)-one-related and tetrahydropyrido[2,3-D]pyrimidin-4(3H)-one-related compounds, compositions and methods for their use
App 20060069106 - Fu; Zice ;   et al.
2006-03-30
Imidazolo-related compounds, compositions and methods for their use
App 20060069127 - Fu; Zice ;   et al.
2006-03-30
Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
App 20060004012 - Akerman; Michelle ;   et al.
2006-01-05
Substituted pyrido[2,3-d]pyrimidines and methods for their use
Grant 6,964,967 - Huang , et al. November 15, 2
2005-11-15
LXR modulators
Grant 6,906,069 - Li , et al. June 14, 2
2005-06-14
CXCR3 antagonists
App 20050075333 - Medina, Julio C. ;   et al.
2005-04-07
Asthma and allergic inflammation modulators
App 20050038070 - Inman, Wayne D. ;   et al.
2005-02-17
CXCR3 antagonists
App 20040242498 - Collins, Tassie L. ;   et al.
2004-12-02
Asthma and allergic inflammation modulators
App 20040220237 - Fu, Zice ;   et al.
2004-11-04
CXCR3 antagonists
Grant 6,794,379 - Medina , et al. September 21, 2
2004-09-21
Modulation of CCR4 function
App 20040039035 - Collins, Tassie ;   et al.
2004-02-26
Hydrazones and analogs as cholesterol lowering agents
Grant 6,605,615 - Medina , et al. August 12, 2
2003-08-12
Benzenesulfonamides and benzamides as therapeutic agents
Grant 6,583,161 - Medina June 24, 2
2003-06-24
CXCR3 antagonists
App 20030069234 - Medina, Julio C. ;   et al.
2003-04-10
CXCR3 antagonists
App 20030055054 - Medina, Julio C. ;   et al.
2003-03-20
Ccr4 antagonists
App 20030018022 - Collins, Tassie ;   et al.
2003-01-23
Modulation of CCR4 function
App 20020173524 - Collins, Tassie ;   et al.
2002-11-21
CXCR3 antagonists
App 20020169159 - Medina, Julio C. ;   et al.
2002-11-14
Hydrazones and analogs as cholesterol lowering agents
App 20010056096 - Medina, Julio C. ;   et al.
2001-12-27
LXR modulators
Grant 6,316,503 - Li , et al. November 13, 2
2001-11-13
HIV integrase inhibitors
Grant 6,306,891 - Selnick , et al. October 23, 2
2001-10-23
Benzenesulfonamides and benzamides as therapeutic agents
Grant 6,191,170 - Medina February 20, 2
2001-02-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed